OcuMedic, Gelest ink drug-delivering contact lens deal

Intersect ENT’s Ascend study misses endpoint

FDA clears Insulet’s OmniPod Dash as insulin pump alternative

ArQule Reports Positive Phase I Data in Haematological Malignancies Study

Harvard Chemists’ Breakthrough in Synthesis Advances a Potent Anti-Cancer Agent

New Vulnerability Found in Major Human Viruses